NCT03267121View on ClinicalTrials.gov

A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

September 30, 2020

Study Completion Date

November 1, 2020

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Apatinib Mesylate Tablets

500 mg qd.p.o. every day for 21 days as a cycle

DRUG

Tegafur Gimeracil Oteracil Potassium Capsules

25mg/㎡ bid p.o. every day for 14 days as a cycle

Trial Locations (1)

200011

Shanghai ninth people's hospital, Shanghai

All Listed Sponsors
lead

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

NCT03267121 - A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter | Biotech Hunter